|
Astrazeneca Pharma India standalone net profit declines 32.06% in the June 2026 quarter> |
|
AstraZeneca Pharma gets CDSCO nod to market Enhertu for additional indication> |
|
Astrazeneca Pharma India announces board meeting date> |
|
AstraZeneca Pharma India announces resignation of CFO> |
|
AstraZeneca Pharma India CFO Bhavana Agrawal resigns> |
|
Astrazeneca Pharma India to conduct AGM> |
|
AstraZeneca Pharma India gets CDSCO nod for additional Fasenra indication> |
|
AstraZeneca Pharma India appoints director corporate affairs> |
|
Astrazeneca Pharma India standalone net profit declines 22.95% in the March 2026 quarter> |
|
Board of Astrazeneca Pharma India recommends final dividend> |